COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study

Serological testing for SARS-CoV-2 IgG antibodies is used to assess their presence in blood samples from exposed individuals and provides a measure of the magnitude of immune response to infection. The measurement of neutralizing antibodies (NAbs) in particular provides information about the severit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sancilio, Amelia, Schrock, Joshua M., Demonbreun, Alexis R., D’Aquila, Richard T., Mustanski, Brian, Vaught, Lauren A., Reiser, Nina L., Velez, Matt P., Hsieh, Ryan R., Ryan, Daniel T., Saber, Rana, McNally, Elizabeth M., McDade, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293881/
https://www.ncbi.nlm.nih.gov/pubmed/35851303
http://dx.doi.org/10.1038/s41598-022-15791-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293881/
https://www.ncbi.nlm.nih.gov/pubmed/35851303
http://dx.doi.org/10.1038/s41598-022-15791-6

Ejemplares similares